Avanos Medical (AVNS) Accumulated Depreciation & Amortization (2013 - 2026)

Avanos Medical's Accumulated Depreciation & Amortization history runs 14 years deep, the most recent figure standing at $10.2 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 6.25% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 6.25% YoY), while the FY2025 annual figure was $38.9 million, down 14.51% from the prior year.
• Accumulated Depreciation & Amortization came in at $10.2 million for Q1 2026 at Avanos Medical, down from $38.9 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $47.7 million in Q4 2022 to a low of $9.6 million in Q1 2025.
• A 5-year average of $26.7 million and a median of $23.6 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization climbed 24.54% in 2022 and fell 15.79% in 2025, its largest moves.
• Avanos Medical's Accumulated Depreciation & Amortization stood at $47.7 million in 2022, then dropped by 3.35% to $46.1 million in 2023, then dropped by 1.3% to $45.5 million in 2024, then declined by 14.51% to $38.9 million in 2025, then sank by 73.78% to $10.2 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $10.2 million, $38.9 million, and $29.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison